Oliveira Antônio C, Oliveira Ana M, Almeida Marcele S, Silva Agnaluce M, Adan Luis, Ladeia Ana M
Bahian School of Medicine and Public Health, Science Development Foundation of Bahia, Bahia, Brazil.
J Pediatr. 2008 Mar;152(3):337-42. doi: 10.1016/j.jpeds.2007.07.013. Epub 2007 Oct 22.
The association between high-sensitivity C-reactive protein (hs-CRP) and alanine aminotransferase (ALT) with clinical/metabolic variables was evaluated in overweight Brazilian children and adolescents.
Oral glucose tolerance test was performed in 407 students (273 overweight/obese, 11.3 +/- 3.1 y). Measurements included body mass index (BMI), waist circumference (WC), blood pressure, lipids, insulin, hs-CRP, and ALT. Overweight/obese was defined using BMI z-score; insulin resistance (IR) by homeostatic model assessment: insulin resistance (HOMA-IR); and metabolic syndrome (MS) in accordance with the modified NCEP-ATPIII.
As weight increased, systolic blood pressure (SBP), diastolic blood pressure (DBP), triglycerides (TG), insulin, HOMA-IR, hs-CRP, ALT, ALT, hs-CRP, and AST and the number of MS components (nMSc) also increased (P </= .001 for all). Subjects with hs-CRP and ALT above the median had higher BMI z-score, WC, SBP, DBP, TG, AST, insulin, HOMA-IR, and nMSc than those with both markers below the median (P </= .002 for all). After adjustment for age, sex and ethnicity, BMI z-score (OR, 1.5; CI, 1.38 to 1.86; P < .001), WC (OR,1.3; CI, 1.19 to 1.43; P < .001) SBP (OR, 1.2; CI, 1.03 to 1.38; P = .015), DBP (OR, 1.4; CI, 1.15 to 1.69; P < .001), TG (OR, 1.8; CI, 1.29 to 2.62; P < .001), insulin (OR, 1.4; CI, 1.23 to 1.71; P < .001), HOMA-IR (OR, 1.2; CI, 1.09 to 1.29; P < .001) and nMSc (OR, 2; CI, 1.16 to 3.47; P = .012) were independently associated with high ALT and hs-CRP. For every 5-cm increase in WC and every 1-point increase in BMI z-score, there were a 1.3- and 1.5-fold greater chance of having increased ALT and hs-CRP, respectively.
Simultaneous measurements of ALT and hs-CRP should be considered as a screening test for metabolic syndrome and cardiovascular disease risk factors in overweight/obese children/adolescents.
在超重的巴西儿童和青少年中,评估高敏C反应蛋白(hs-CRP)和丙氨酸转氨酶(ALT)与临床/代谢变量之间的关联。
对407名学生(273名超重/肥胖,年龄11.3±3.1岁)进行口服葡萄糖耐量试验。测量指标包括体重指数(BMI)、腰围(WC)、血压、血脂、胰岛素、hs-CRP和ALT。超重/肥胖通过BMI z评分定义;胰岛素抵抗(IR)采用稳态模型评估:胰岛素抵抗(HOMA-IR);代谢综合征(MS)根据改良的NCEP-ATPIII标准诊断。
随着体重增加,收缩压(SBP)、舒张压(DBP)、甘油三酯(TG)、胰岛素、HOMA-IR、hs-CRP、ALT、AST以及代谢综合征组分数量(nMSc)也增加(所有P≤0.001)。hs-CRP和ALT高于中位数的受试者比两者均低于中位数的受试者具有更高的BMI z评分、WC、SBP、DBP、TG、AST、胰岛素、HOMA-IR和nMSc(所有P≤0.002)。在调整年龄、性别和种族后,BMI z评分(比值比[OR],1.5;置信区间[CI],1.38至1.86;P<0.001)、WC(OR,1.3;CI,1.19至1.43;P<0.001)、SBP(OR,1.2;CI,1.03至1.38;P = 0.015)、DBP(OR,1.4;CI,1.15至1.69;P<0.001)、TG(OR,1.8;CI,1.29至2.62;P<0.001)、胰岛素(OR,1.4;CI,1.23至1.71;P<0.001)、HOMA-IR(OR,1.2;CI,1.09至1.29;P<0.001)和nMSc(OR,2;CI,1.16至3.47;P = 0.012)与高ALT和hs-CRP独立相关。WC每增加5 cm,BMI z评分每增加1分,ALT和hs-CRP升高的可能性分别增加1.3倍和1.5倍。
对于超重/肥胖儿童/青少年,应考虑同时检测ALT和hs-CRP作为代谢综合征和心血管疾病危险因素的筛查试验。